Charles W Drescher

Charles W Drescher

UNVERIFIED PROFILE

Are you Charles W Drescher?   Register this Author

Register author
Charles W Drescher

Charles W Drescher

Publications by authors named "Charles W Drescher"

Are you Charles W Drescher?   Register this Author

49Publications

1006Reads

35Profile Views

The Yet Unrealized Promise of Ovarian Cancer Screening.

JAMA Oncol 2018 04;4(4):456-457

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0028DOI Listing
April 2018

Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.

Neoplasia 2017 Jun 9;19(6):471-482. Epub 2017 May 9.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2017.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429243PMC
June 2017

Targeted single molecule mutation detection with massively parallel sequencing.

Nucleic Acids Res 2016 Feb 17;44(3):e22. Epub 2015 Sep 17.

Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA Department of Pathology, University of Washington, Seattle, WA 98195, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkv915DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756847PMC
February 2016

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.

Gynecol Oncol 2016 Jan 30;140(1):138-44. Epub 2015 Oct 30.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.10.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310763PMC
January 2016

Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.

Clin Cancer Res 2014 Mar 3;20(5):1313-22. Epub 2014 Jan 3.

Authors' Affiliations: Departments of Radiology and Bioengineering and Materials Science and Engineering; Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California; and Division of Public Health Sciences, Fred Hutchinson, Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1642DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965293PMC
March 2014

Digital genomic quantification of tumor-infiltrating lymphocytes.

Sci Transl Med 2013 Dec;5(214):214ra169

Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3007247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026017PMC
December 2013

Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

J Altern Complement Med 2013 Aug 27;19(8):714-20. Epub 2013 Feb 27.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/acm.2012.0295DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731675PMC
August 2013

Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.

Cancer Epidemiol Biomarkers Prev 2012 Nov 7;21(11):2087-94. Epub 2012 Sep 7.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M2-B230, P.O. Box 19024, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-12-0616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493821PMC
November 2012

Involvement in decision-making about treatment and ovarian cancer survivor quality of life.

Gynecol Oncol 2012 Mar 29;124(3):465-70. Epub 2011 Oct 29.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.10.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727540PMC
March 2012

ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma.

PLoS Biol 2011 Sep 20;9(9):e1001156. Epub 2011 Sep 20.

Department of Biochemistry, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pbio.1001156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176749PMC
September 2011

Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases.

Am J Obstet Gynecol 2011 Jun 16;204(6):551.e1-9. Epub 2011 Mar 16.

Pacific Gynecology Specialists Inc, Swedish Medical Center, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2011.01.059DOI Listing
June 2011

Early diagnosis of ovarian carcinoma: is a solution in sight?

Radiology 2011 May;259(2):329-45

Department of Radiology, Bio-X Program, Stanford University School of Medicine, 318 Campus Dr, Room E150, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.11090563DOI Listing
May 2011

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Gynecol Oncol 2010 Mar 28;116(3):378-83. Epub 2009 Nov 28.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.10.087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822097PMC
March 2010

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.

PLoS One 2010 Feb 22;5(2):e9359. Epub 2010 Feb 22.

Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009359PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825254PMC
February 2010

Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging.

Am J Obstet Gynecol 2008 Jun;198(6):679.e1-9; discussion 679.e9-10

Pacific Gynecology Specialists, Inc., Swedish Medical Center, Seattle WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2008.03.032DOI Listing
June 2008

Changes in cancer worry associated with participation in ovarian cancer screening.

Psychooncology 2007 Sep;16(9):814-20

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.1151DOI Listing
September 2007

Development of an ovarian cancer symptom index: possibilities for earlier detection.

Cancer 2007 Jan;109(2):221-7

Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, Washington 98196-6460, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22371DOI Listing
January 2007

Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis.

Gynecol Oncol 2006 Dec 22;103(3):1130-2. Epub 2006 Sep 22.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Washington Medical Center, Box 356460, Seattle, WA 98195-6460, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.06.044DOI Listing
December 2006

Bead-based ELISA for validation of ovarian cancer early detection markers.

Clin Cancer Res 2006 Apr;12(7 Pt 1):2117-24

Translational Outcomes Research Laboratory, Fred Hutchinson Cancer Research Center, Public Health Sciences, and Harborview Medical Center, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-05-2007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734269PMC
April 2006

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.

J Clin Oncol 2006 Feb 3;24(5):762-8. Epub 2006 Jan 3.

Center for Translational Medicine in Women's Health, Tumor Vaccine Group, University of Washington, and the Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.2813DOI Listing
February 2006

Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.

Cancer Epidemiol Biomarkers Prev 2004 Apr;13(4):600-6

Swedish Hospital and Medical Center, 1101 Madison Street, Suite 1500, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
April 2004

Adequate staging for uterine cancer can be performed through Pfannenstiel incisions.

Gynecol Oncol 2003 Mar;88(3):404-10

Washington University School of Medicine, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-8258(02)00166-xDOI Listing
March 2003

Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian cancer.

Gynecol Oncol 2003 Feb;88(2):136-40

Gynecologic Oncology Associates, Hoag Memorial Hospital Cancer Center, Newport Beach, CA 92663, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-8258(02)00021-5DOI Listing
February 2003